These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 2904269

  • 1. Special pharmacology of the new sulfonylurea glimepiride.
    Geisen K.
    Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
    [Abstract] [Full Text] [Related]

  • 2. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE, Matthews DR.
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [Abstract] [Full Text] [Related]

  • 3. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
    Jorgensen KD.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
    [Abstract] [Full Text] [Related]

  • 4. Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas.
    Ledercq-Meyer V, Akkan AG, Marchand J, Malaisse WJ.
    Biochem Pharmacol; 1991 Sep 27; 42(8):1634-7. PubMed ID: 1930290
    [Abstract] [Full Text] [Related]

  • 5. [Current concepts of the pancreatic and extrapancreatic mechanisms of the action of peroral hypoglycemic sulfonylurea preparations].
    Poltorak VV, Gladkikh AI.
    Probl Endokrinol (Mosk); 1985 Sep 27; 31(2):76-85. PubMed ID: 2859589
    [No Abstract] [Full Text] [Related]

  • 6. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas.
    Efendić S, Enzmann F, Nylén A, Uvnäs-Wallensten K, Luft R.
    Proc Natl Acad Sci U S A; 1979 Nov 27; 76(11):5901-4. PubMed ID: 118458
    [Abstract] [Full Text] [Related]

  • 7. Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.
    Müller G, Satoh Y, Geisen K.
    Diabetes Res Clin Pract; 1995 Aug 27; 28 Suppl():S115-37. PubMed ID: 8529504
    [Abstract] [Full Text] [Related]

  • 8. Unaltered glucagon secretion after seven days of sulphonylurea administration in normal subjects.
    Marco J, Valverde I.
    Diabetologia; 1973 Sep 27; ():317-9. PubMed ID: 4204092
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A, Ribes G, Mariani MM, Alric R.
    Acta Diabetol Lat; 1973 Sep 27; 10(2):261-82. PubMed ID: 4200420
    [No Abstract] [Full Text] [Related]

  • 10. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo (b) furan-7-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). II. Pharmacological studies on the mechanism of action.
    Jorgensen KD.
    Acta Pharmacol Toxicol (Copenh); 1977 Feb 27; 40(2):227-33. PubMed ID: 190857
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations.
    Gregorio F, Ambrosi F, Cristallini S, Filipponi P, Santeusanio F.
    Acta Diabetol; 1996 Mar 27; 33(1):25-9. PubMed ID: 8777281
    [Abstract] [Full Text] [Related]

  • 14. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
    Szoke E, Gosmanov NR, Sinkin JC, Nihalani A, Fender AB, Cryer PE, Meyer C, Gerich JE.
    Metabolism; 2006 Jan 27; 55(1):78-83. PubMed ID: 16324923
    [Abstract] [Full Text] [Related]

  • 15. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
    Duhault J, Boulanger M, Tisserand F, Bergi L.
    Arzneimittelforschung; 1972 Oct 27; 22(10):1682-5. PubMed ID: 4677056
    [No Abstract] [Full Text] [Related]

  • 16. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J, Haupt E, Cordes U, Kutschera J, Schöffling K.
    Horm Metab Res; 1973 Jan 27; 5(1):9-13. PubMed ID: 4196346
    [No Abstract] [Full Text] [Related]

  • 17. Comparative effects of glimepiride and glibenclamide on blood glucose, C-peptide and insulin concentrations in the fasting and postprandial state in normal man.
    Raptis SA, Hatziagelaki E, Dimitriadis G, Draeger KE, Pfeiffer C, Raptis AE.
    Exp Clin Endocrinol Diabetes; 1999 Jan 27; 107(6):350-5. PubMed ID: 10543411
    [Abstract] [Full Text] [Related]

  • 18. Repaglinide, glibenclamide and glimepiride administration to normal and hereditarily diabetic rats.
    Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse WJ.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):227-34. PubMed ID: 9369378
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.